Arcus Biosciences
RCUS
RCUS
139 hedge funds and large institutions have $1.03B invested in Arcus Biosciences in 2020 Q2 according to their latest regulatory filings, with 59 funds opening new positions, 48 increasing their positions, 24 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
51% more funds holding
Funds holding: 92 → 139 (+47)
14.61% more ownership
Funds ownership: 58.73% → 73.34% (+15%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
139
Holding in Top 10
4
Calls
$3.44M
Puts
$661K
Top Buyers
| 1 | +$65M | |
| 2 | +$45.6M | |
| 3 | +$37.6M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$24.7M |
| 5 |
State Street
Boston,
Massachusetts
|
+$23.4M |
Top Sellers
| 1 | -$43.9M | |
| 2 | -$24.7M | |
| 3 | -$5.82M | |
| 4 |
ACM
Aisling Capital Management
New York
|
-$4.63M |
| 5 |
Renaissance Technologies
New York
|
-$3.63M |